Judge Affirms $4.69B Verdict in Baby Powder Cancer Lawsuit

Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Judge using gavel

A Missouri judge’s decision last week to uphold a $4.69 billion verdict could encourage more people to file talcum powder lawsuits against Johnson & Johnson, legal experts say.

“Verdicts like these give women a sense of validation and a sense that everything they are suffering is not going to be in vain,” lawyer and women’s health advocate Holly Ennis told Drugwatch. “I think verdicts like these definitely help future cases.”

On Aug. 22, 2018, Judge Rex Burlison of the Circuit Court of the City of St. Louis affirmed jurors’ decision to award 22 women and their families $25 million each.

Talcum powder lawyer Mark Lanier represented the women. He argued that asbestos in Johnson & Johnson’s Baby Powder and other talcum powder products led to the development of ovarian cancer. Six of the women died.

The case marks the first time Lanier argued that asbestos — and not just talc — caused the women’s ovarian cancer, according to Courtroom View Network. Previous talcum powder cases argued that talc alone caused the cancer.

Diagnosed with cancer after talcum powder use? Get a Free Case Review

Regulatory authorities such as the U.S. Food and Drug Administration and World Health Organization recognize asbestos as a carcinogen. It is linked to the aggressive cancer mesothelioma.

Because talc and asbestos occur naturally together, asbestos may contaminate talc after mining. The FDA cannot guarantee that cosmetic talc products in the U.S. do not contain asbestos, according to its Talc web page.

Johnson & Johnson maintains that its talcum powder products are safe. The company said in a July 12 statement that it was “deeply disappointed in the verdict” and blamed “a fundamentally unfair process.” It plans to continue to appeal the Missouri court decision.

An appellate court may reduce the $4.69 billion jury verdict, Ennis told Drugwatch. But it could lead to a global settlement for Johnson & Johnson talc claims.

“It sends a clear message to J&J,” Ennis said. “It will most likely initiate a global resolution of the claims because J&J is not going to want to do this over and over again.”

Johnson & Johnson still faces about 10,600 talcum powder lawsuits, the company said in its Aug. 2, 2018, quarterly report filing.

On Aug. 20, 2018, a trial started in Los Angeles in a lawsuit claiming Johnson’s Baby Powder led to a woman’s mesothelioma.

  •  
  •  
  •  
Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for seven years. She specializes in fluoroquinolone antibiotics, vaccines and products that affect women’s health such as Essure birth control, transvaginal mesh and talcum powder. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • American Medical Writers Association (AMWA) Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine

6 Cited Research Articles

  1. Sammon, J. (2018, August 21). Trial opens accusing Johnson & Johnson talc powder of causing mesothelioma. Retrieved from https://norcalrecord.com/stories/511539347-trial-opens-accusing-johnson-johnson-talc-powder-of-causing-mesothelioma
  2. Bellon, T. (2018, August 22). Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal. Retrirved from https://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit/missouri-judge-affirms-4-69-billion-talc-verdict-jj-vows-to-appeal-idUSKCN1L721E
  3. Siegel, D. (2018, July 6). Closing arguments set for July 11 in massive 22-plaintiff J&J talc powder trial. Retrieved from http://blog.cvn.com/closing-arguments-set-for-july-11-in-massive-22-plaintiff-jj-talc-powder-trial
  4. Johnson & Johnson. (2018, July 12). Johnson & Johnson Issues Statement Regarding Verdict in St. Louis. Retrieved from https://www.jnj.com/our-company/johnson-johnson-issues-statement-regarding-verdict-st-louis-missouri-court
  5. FDA. (n.d.). Talc Retrieved from https://www.fda.gov/cosmetics/productsingredients/ingredients/ucm293184.htm
  6. Johnson & Johnson. (2018, August 2). Quarterly Report, Form 10-Q. Retrieved from http://www.investor.jnj.com/sec.cfm
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(855) 547-5876